Chutani S, Imran N, Grubb B, Kanjwal Y
Department of Cardiovascular Medicine, University of Toledo Medical Center, Toledo, Ohio, USA.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.12.2008.1389. Epub 2009 May 13.
Brugada syndrome is one of the important causes of sudden cardiac death in young adults. The condition is associated with typical electrocardiogram (ECG) changes in anteroseptal leads V1 and V2 that can be unmasked by various medications, electrolyte disturbances, and even by the febrile state in susceptible individuals. The case history is reported of a patient with atrial flutter and atrial fibrillation who developed Brugada-like ECG changes when treated with propafenone. He was mistakenly diagnosed as having acute myocardial infarction when he presented to the emergency room with acute precordial chest pain. Cardiac catheterisation revealed normal coronary arteries and normal left ventricular systolic function. A review of previous ECGs showed the temporal relationship of ECG changes to initiation of propafenone a few years earlier. The ECG changes resolved with discontinuation of propafenone and re-emerged when he was rechallenged with oral propafenone. This case highlights the importance of recognising the characteristic ECG changes of Brugada syndrome and being able to differentiate them from those of acute myocardial infarction and other conditions manifesting with similar changes.
Brugada综合征是年轻成年人心脏性猝死的重要原因之一。该病症与前间隔导联V1和V2典型的心电图(ECG)改变相关,这些改变可被各种药物、电解质紊乱,甚至易感个体的发热状态所揭示。本文报告了1例心房扑动和心房颤动患者,在使用普罗帕酮治疗时出现了类似Brugada综合征的ECG改变。他因急性心前区胸痛就诊于急诊室时被误诊为急性心肌梗死。心脏导管检查显示冠状动脉正常且左心室收缩功能正常。回顾既往心电图发现,ECG改变与数年前开始使用普罗帕酮存在时间上的关联。停用普罗帕酮后ECG改变消失,再次口服普罗帕酮时又重新出现。该病例强调了认识Brugada综合征特征性ECG改变并能够将其与急性心肌梗死及其他表现出类似改变的病症相鉴别的重要性。